Singular Genomics Systems, Inc. (OMIC)
USD 19.6
(-0.56%)
USD 19.6
(-0.56%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -558 Thousand USD | -2225.0% |
| 2022 | -24 Thousand USD | 97.88% |
| 2021 | -1.13 Million USD | -77.31% |
| 2020 | -639 Thousand USD | -82.57% |
| 2019 | -350 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -178 Thousand USD | 91.69% |
| 2024 Q1 | -2.14 Million USD | -368.49% |
| 2023 Q3 | -65 Thousand USD | 29.35% |
| 2023 FY | -558 Thousand USD | -2225.0% |
| 2023 Q4 | -457 Thousand USD | -603.08% |
| 2023 Q2 | -92 Thousand USD | -264.29% |
| 2023 Q1 | 56 Thousand USD | 333.33% |
| 2022 Q2 | -1.54 Million USD | -234.49% |
| 2022 Q1 | -461 Thousand USD | -26.65% |
| 2022 FY | -24 Thousand USD | 97.88% |
| 2022 Q4 | -24 Thousand USD | 98.56% |
| 2022 Q3 | -1.66 Million USD | -8.11% |
| 2021 FY | -1.13 Million USD | -77.31% |
| 2021 Q4 | -364 Thousand USD | -20.13% |
| 2021 Q3 | -303 Thousand USD | -18.82% |
| 2021 Q1 | -211 Thousand USD | 0.0% |
| 2021 Q2 | -255 Thousand USD | -20.85% |
| 2020 FY | -639 Thousand USD | -82.57% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | -350 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | 100.991% |
| AngioDynamics, Inc. | 154.69 Million USD | 100.361% |
| AtriCure, Inc. | 300.37 Million USD | 100.186% |
| Avinger, Inc. | 2 Million USD | 127.858% |
| Azenta, Inc. | 263.14 Million USD | 100.212% |
| BioLife Solutions, Inc. | 46.75 Million USD | 101.194% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 100.024% |
| Daxor Corporation | 1.1 Million USD | 150.569% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | 106.146% |
| Femasys Inc. | 691.9 Thousand USD | 180.647% |
| GlucoTrack, Inc. | -13 Thousand USD | -4192.308% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 100.917% |
| Hologic, Inc. | 2.22 Billion USD | 100.025% |
| ICU Medical, Inc. | 739.87 Million USD | 100.075% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 100.012% |
| KORU Medical Systems, Inc. | 16.7 Million USD | 103.34% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 100.439% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | -367.615% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | -367.615% |
| Masimo Corporation | 1 Billion USD | 100.056% |
| Microbot Medical Inc. | -106 Thousand USD | -426.415% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 101.686% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 100.096% |
| Nephros, Inc. | 8.4 Million USD | 106.639% |
| NovoCure Limited | 381.05 Million USD | 100.146% |
| NEXGEL, Inc. | 619 Thousand USD | 190.145% |
| NEXGEL, Inc. | 619 Thousand USD | 190.145% |
| OraSure Technologies, Inc. | 179.42 Million USD | 100.311% |
| Pro-Dex, Inc. | 14.55 Million USD | 103.835% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 53.77% |
| Predictive Oncology Inc. | 1.14 Million USD | 148.721% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | 109.624% |
| QuidelOrtho Corporation | 1.49 Billion USD | 100.037% |
| Repligen Corporation | 315.22 Million USD | 100.177% |
| Sanara MedTech Inc. | 57.13 Million USD | 100.977% |
| STAAR Surgical Company | 252.65 Million USD | 100.221% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 37.391% |
| Utah Medical Products, Inc. | 30.03 Million USD | 101.858% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 100.027% |
| Jin Medical International Ltd. | 6.78 Million USD | 108.224% |